Toxicity After Stereotactic Body Radiation Therapy for Prostate Cancer in Patients With Inflammatory Bowel Disease: A Multi-institutional Matched Case-Control Series

PURPOSE: To evaluate the safety of stereotactic body radiation therapy (SBRT) for prostate cancer in men with inflammatory bowel disease (IBD). METHODS AND MATERIALS: We queried a consortium database for patients with IBD receiving SBRT for prostate cancer between 2006 and 2012. Identified patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Juarez, Jesus E., Romero, Tahmineh, Mantz, Constantine A., Pepin, Abigail, Aghdam, Nima, Suy, Simeng, Steinberg, Michael L., Levin-Epstein, Rebecca G., Nickols, Nicholas G., Kaplan, Irving D., Meier, Robert M., Pham, Huong T., Linson, Patrick W., Hong, Robert L., Buyyounouski, Mark K., Bagshaw, Hilary P., Fuller, Donald B., Katz, Alan J., Loblaw, Andrew, Collins, Sean P., Kishan, Amar U.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Scientific Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453194/
https://www.ncbi.nlm.nih.gov/pubmed/34585025
http://dx.doi.org/10.1016/j.adro.2021.100759

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8453194/
https://www.ncbi.nlm.nih.gov/pubmed/34585025
http://dx.doi.org/10.1016/j.adro.2021.100759

Ejemplares similares